Himalaya Nutravedics India Limited manufactures, markets and distributes Ayurvedic and nutraceutical products in India and also undertakes third-party contract manufacturing. Its portfolio includes classical and proprietary Ayurvedic formulations and nutraceutical supplements across various dosage forms.
The Company follows a hybrid business model combining own branded products with third-party manufacturing. It began manufacturing in September 2022 at its Cherlapally, Hyderabad facility, initially relying mainly on third-party manufacturing before expanding its own product business.
Its own-brand portfolio includes classical and proprietary Ayurvedic formulations and nutraceutical supplements, covering various therapeutic and wellness areas through a doctor-centric marketing approach and pan-India distribution network.
The Company operates a WHO-GMP compliant manufacturing facility in Hyderabad, with certifications and licences including ISO 9001:2015, ISO 22000:2018, FSSAI and AYUSH, supporting its Ayurvedic and nutraceutical product portfolio.
As of July 31, 2026, the Company employed a total of 86 personnel.
Himalaya Nutravedics India IPO – Details
| IPO Opening Date | 22 September 2026 |
| IPO Closing Date | 24 September 2026 |
| Issue Type | Book Building IPO |
| Issue Size | Total Issue: 24,99,600 Shares Worth ₹26.50 Crore Fresh Issue: 24,99,600 Shares Worth ₹26.50 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹100 – ₹106 per share |
| Market Lot | 1200 Shares |
| Min Order | 1200 Shares [ 1 Lot ] |
| Listing At | BSE SME |
| Registrar | Kfin Technologies Ltd. |
| QIB Shares Offered | 50% |
| NII Shares Offered | 15% |
| Retail Shares Offered | 35% |
Himalaya Nutravedics India IPO – Date Schedule
| IPO Open Date | 22 September 2026 |
| IPO Close Date | 24 September 2026 |
| Basis of Allotment | 25 September 2026 |
| Initiation of Refund | 28 September 2026 |
| Credit of Shares to Demat | 28 September 2026 |
| IPO Listing Date | 29 September 2026 |
| Cut-off time for UPI mandate confirmation | 5 PM on September 24, 2026 |
Himalaya Nutravedics India IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2400 | ₹2,54,400 |
| Retail (Max) | 2 | 2400 | ₹2,54,400 |
| S-HNI (Min) | 3 | 3600 | ₹3,81,600 |
| S-HNI (Max) | 7 | 8400 | ₹8,90,400 |
| B-HNI (Min) | 8 | 9600 | ₹10,17,600 |
Competitive Strength
- Integrated multi-dosage manufacturing capability.
- Doctor acceptance supported by product performance rather than mass advertising.
- Long-standing relationships with suppliers and customers.
- Geographic expansion over a short operating history.
- Broad therapeutic coverage across Ayurvedic and nutraceutical segments.
Company Promoters
- Rohit Asawa
- Divya Asawa
- Chanda Asawa
- Rama Raju Penmatsas
Company Financials
| Period | Total Revenue | Total Expense | Profit After Tax | Total Borrowing |
|---|---|---|---|---|
| 31 March 2024 | ₹14.43 Cr | ₹13.83 Cr | ₹0.43 Cr | ₹3.24 Cr |
| 31 March 2025 | ₹21.00 Cr | ₹18.75 Cr | ₹2.23 Cr | ₹1.76 Cr |
| 31 March 2026 | ₹43.12 Cr | ₹35.64 Cr | ₹7.39 Cr | ₹5.13 Cr |
Key Performance Indicator
| KPI | Values (Mar 31, 2026) |
|---|---|
| ROE | 63.87% |
| ROCE | 36.41% |
| Debt/Equity | 0.31 |
| RoNW | 45.12% |
| PAT Margin | 17.16% |
| EBITDA Margin | 18.82% |
| NAV | 26.70 |
| Price to Book Value | 3.97 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 11.72 | 8.39 |
| P/E (x) | 9.04 | 12.63 |
Object Of The Issue
| Objects of the Issue | Expected Amount (in Crore) |
|---|---|
| Funding Working Capital Requirements. | ₹13.75 |
| Business Development and Digital Marketing Activities. | ₹7.50 |
| General Corporate Purposes. |
✅Strengths
- Diversified Product Portfolio with classical Ayurvedic, proprietary Ayurvedic and nutraceutical products.
- Hybrid Business Model combining own branded products with third-party contract manufacturing.
- Doctor-Centric Approach supported by a pan-India distribution network.
- WHO-GMP Manufacturing Facility with multiple quality certifications and applicable AYUSH and FSSAI licences.
- Strong Financial Growth with improvement in revenue, EBITDA and PAT over FY2024–FY2026.
⚠️Risks
- Limited Operating History as the Company commenced operations only in 2022.
- Single Manufacturing Facility creates dependence on one production location.
- Third-Party Manufacturing Dependence exposes the Company to risks associated with contract manufacturing relationships.
- Trademark Opposition proceedings relating to the Company’s corporate trademarks are currently pending.
- Competitive Industry with established players operating across the Ayurvedic and nutraceutical segments.
Himalaya Nutravedics India IPO Promoter Holding
| Pre-Issue Share Holding | 95.14% |
| Post Issue Share Holding | 69.94% |
Himalaya Nutravedics India IPO Prospectus
Company Contact Information
| Himalaya Nutravedics India Limited Plot No. 101/A, Phase-III, Industrial Development Park, Cherlapally, Hindustan Cables Ltd, Uppal Hyderabad, Telangana, 500051 Phone: +91-9063498493 Email: info@himalayanutravedics.com Website: https://himalayanutravedics.com/ |
Himalaya Nutravedics India IPO Registrar
| Kfin Technologies Ltd. Phone: 040-79615565 Email: himalaya.ipo@kfintech.com Website: https://ipostatus.kfintech.com/ |
Himalaya Nutravedics India IPO Lead Manager(s)
| 1. Nirbhay Capital Services Pvt.Ltd. |
Himalaya Nutravedics India IPO FAQ
| What is the Himalaya Nutravedics India IPO? Himalaya Nutravedics India IPO is an SME IPO. The issue is priced at ₹100 – ₹106 per equity share. The IPO is to be listed on BSE SME. |
| When will Himalaya Nutravedics India IPO open? The IPO is to open on 22 September 2026 for QIB, NII and Retail Investors. |
| What is Himalaya Nutravedics India IPO Investors’ Portion? The Investors portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| What is the Himalaya Nutravedics India IPO Size? Himalaya Nutravedics India IPO size is ₹26.50 Crore. |
| What are the Himalaya Nutravedics India IPO Minimum and Maximum Lot Sizes for Retail Investors? The minimum bid is 2400 Shares for ₹2,54,400, while the maximum bid is 2400 Shares for ₹2,54,400. |
| What is the Himalaya Nutravedics India IPO Allotment Date? Himalaya Nutravedics India IPO allotment date is 25 September 2026. |
| What is the Himalaya Nutravedics India IPO Listing Date? Himalaya Nutravedics India IPO listing date is 29 September 2026. The IPO is to be listed on the BSE SME. |
